Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Some birth control pills increase blood clot risk; use them for specific conditions only.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Tocilizumab might be an effective treatment for COVID-19.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

34% of patients on hepatitis C treatment had reversible skin issues.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.